Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Discov. 2012 Nov;2(11):974-5. doi: 10.1158/2159-8290.CD-12-0432. Epub 2012 Oct 23.

The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.

Author information

1
Department of Tumour Biology, Centre of Experimental Medicine, University Cancer Center Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. pantel@uke.uni-hamburg.de

Abstract

Miyamoto and colleagues present data that prostate-specific antigen/prostate-specific membrane antigen (PSA/PSMA)-based measurements of androgen receptor (AR) signaling in circulating tumor cells (CTC) enable real-time quantitative monitoring of intratumoral AR signaling. This finding indicates that measuring AR signaling within CTCs may help to guide therapy in metastatic prostate cancer and highlights the use of CTCs as liquid biopsy.

PMID:
23093252
DOI:
10.1158/2159-8290.CD-12-0432
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center